 |
 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Classifying Types of Bacterial Infections
19 November 2002 | Volume 137 Issue 10 | Page I-36
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full report titled "Health Care–Associated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections." It is in the 19 November 2002 issue of Annals of Internal Medicine (volume 137, pages 791-797). The authors are ND Friedman, KS Kaye, JE Stout, SA McGarry, SL Trivette, JP Briggs, W Lamm, C Clark, J MacFarquhar, AL Walton, LB Reller, and DJ Sexton.
What is the problem and what is known about it so far?
Bacteria entering the blood can cause serious problems called bloodstream infections (bacteremia). In the past, doctors classified bloodstream infections as community-acquired or nosocomial. Community-acquired infections occurred in otherwise relatively healthy outpatients. Nosocomial infections occurred in very sick hospitalized patients. Doctors chose antibiotic drugs on the basis of the two kinds of infections because different types of bacteria typically caused them. In the past decade, sicker patients with complicated illnesses such as cancer and kidney failure requiring dialysis are routinely cared for in outpatient settings. Bacteremia in these sicker outpatients may be more like nosocomial infections than like community-acquired infections.
Why did the researchers do this particular study?
To develop a more useful classification system for bloodstream infections.
Who was studied?
504 adults with symptoms or signs of infection and positive blood cultures.
How was the study done?
The researchers reviewed blood culture reports of hospitalized patients from one academic medical center and two community hospitals in North Carolina. They then reviewed medical records of patients with positive blood cultures to learn about symptoms, signs, and sites of infection and medical conditions and treatments. They placed the patients into one of three groups (community-acquired, health care–associated, and nosocomial) and compared infection and patient characteristics across groups. The nosocomial group first had positive blood cultures at least 48 hours after hospitalization for another problem. The health care–associated group had positive blood cultures at the time of or within 48 hours of hospitalization and had recently needed complicated care (nursing home and dialysis patients, patients recently hospitalized, and patients recently given medicine in a vein [intravenous] at home). The community-acquired group first had positive blood cultures at the time of or within 48 hours of hospitalization but did not fit criteria for a health care–associated infection.
What did the researchers find?
Patients with community-acquired infections less often had cancer than patients in the other groups. The most common source of bloodstream infection differed by group: urinary tract infections in the community-acquired group and tubes inserted in veins to give treatment in the other groups. Two bacteria (Escherichia coli and Streptococcus pneumoniae) frequently caused community-acquired infections. Staphylococcus aureus frequently caused health care–associated and nosocomial infections. Bacteria resistant to antibiotics were infrequent with community-acquired infections. More patients with nosocomial infections (37%) died than patients with health care–associated (29%) and community-acquired (16%) infections.
What were the limitations of the study?
The study was from one area in North Carolina. Patterns of health care and infections may vary in different areas. The definition of health care–associated infection was broad and included patients with different risks for infection.
What are the implications of the study?
Health care–associated bloodstream infections acquired in the outpatient setting are different from community-acquired bloodstream infections in relatively healthy people.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  M. Venditti, M. Falcone, S. Corrao, G. Licata, P. Serra, and the Study Group of the Italian Society of Internal Outcomes of Patients Hospitalized With Community-Acquired, Health Care-Associated, and Hospital-Acquired Pneumonia Ann Intern Med, January 6, 2009; 150(1): 19 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Marschall, R. J. Tibbetts, W. M. Dunne Jr., J. G. Frye, V. J. Fraser, and D. K. Warren Presence of the KPC Carbapenemase Gene in Enterobacteriaceae Causing Bacteremia and Its Correlation with In Vitro Carbapenem Susceptibility J. Clin. Microbiol., January 1, 2009; 47(1): 239 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Shorr, M. D. Zilberberg, S. T. Micek, and M. H. Kollef Prediction of Infection Due to Antibiotic-Resistant Bacteria by Select Risk Factors for Health Care-Associated Pneumonia Arch Intern Med, November 10, 2008; 168(20): 2205 - 2210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Durante-Mangoni, S. Bradley, C. Selton-Suty, M.-F. Tripodi, B. Barsic, E. Bouza, C. H. Cabell, A. I. d. O. Ramos, V. Fowler Jr, B. Hoen, et al. Current Features of Infective Endocarditis in Elderly Patients: Results of the International Collaboration on Endocarditis Prospective Cohort Study Arch Intern Med, October 27, 2008; 168(19): 2095 - 2103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Wargo, E. H. Eiland III, and L. S. Eiland Management and Treatment Considerations for Infections Caused by Methicillin-Resistant Staphylococcus aureus Journal of Pharmacy Practice, October 1, 2008; 21(5): 324 - 336. [Abstract] [PDF]
|
|
|
|
|
|
J. Rodriguez-Bano, J. C. Alcala, J. M. Cisneros, F. Grill, A. Oliver, J. P. Horcajada, T. Tortola, B. Mirelis, G. Navarro, M. Cuenca, et al. Community Infections Caused by Extended-Spectrum {beta}-Lactamase-Producing Escherichia coli Arch Intern Med, September 22, 2008; 168(17): 1897 - 1902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tumbarello, M. Sali, E. M. Trecarichi, F. Leone, M. Rossi, B. Fiori, G. De Pascale, T. D'Inzeo, M. Sanguinetti, G. Fadda, et al. Bloodstream Infections Caused by Extended-Spectrum-{beta}-Lactamase- Producing Escherichia coli: Risk Factors for Inadequate Initial Antimicrobial Therapy Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3244 - 3252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.-L. Lu, J.-C. Tsai, Y.-W. Chiu, F.-Y. Chang, Y.-W. Chen, C.-F. Hsiao, and L. K. Siu Methicillin-resistant Staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1659 - 1665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Ashour and A. El-Sharif Microbial Spectrum and Antibiotic Susceptibility Profile of Gram-Positive Aerobic Bacteria Isolated From Cancer Patients J. Clin. Oncol., December 20, 2007; 25(36): 5763 - 5769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Morpeth, D. Murdoch, C. H. Cabell, A. W. Karchmer, P. Pappas, D. Levine, F. Nacinovich, P. Tattevin, N. Fernandez-Hidalgo, S. Dickerman, et al. Non-HACEK Gram-Negative Bacillus Endocarditis Ann Intern Med, December 18, 2007; 147(12): 829 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Cheong, C.-I. Kang, K. T. Kwon, S. T. Heo, Y. M. Wi, E. S. Kim, J. S. Lee, K. S. Ko, D. R. Chung, N. Y. Lee, et al. Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia J. Antimicrob. Chemother., December 1, 2007; 60(6): 1355 - 1360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Freundlich, R. W. Thomsen, L. Pedersen, H. West, and H. C. Schonheyder Aminoglycoside treatment and mortality after bacteraemia in patients given appropriate empirical therapy: a Danish hospital-based cohort study J. Antimicrob. Chemother., November 1, 2007; 60(5): 1115 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hawkins, J. Huang, N. Jin, G. A. Noskin, T. R. Zembower, and M. Bolon Persistent Staphylococcus aureus Bacteremia: An Analysis of Risk Factors and Outcomes Arch Intern Med, September 24, 2007; 167(17): 1861 - 1867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Carratala, A. Mykietiuk, N. Fernandez-Sabe, C. Suarez, J. Dorca, R. Verdaguer, F. Manresa, and F. Gudiol Health Care-Associated Pneumonia Requiring Hospital Admission: Epidemiology, Antibiotic Therapy, and Clinical Outcomes Arch Intern Med, July 9, 2007; 167(13): 1393 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Daikos, C. Kosmidis, P. T. Tassios, G. Petrikkos, A. Vasilakopoulou, M. Psychogiou, I. Stefanou, A. Avlami, and N. Katsilambros Enterobacteriaceae Bloodstream Infections: Presence of Integrons, Risk Factors, and Outcome Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2366 - 2372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tumbarello, B. Posteraro, E. M. Trecarichi, B. Fiori, M. Rossi, R. Porta, K. de Gaetano Donati, M. La Sorda, T. Spanu, G. Fadda, et al. Biofilm Production by Candida Species and Inadequate Antifungal Therapy as Predictors of Mortality for Patients with Candidemia J. Clin. Microbiol., June 1, 2007; 45(6): 1843 - 1850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Z. Uslan, S. J. Crane, J. M. Steckelberg, F. R. Cockerill III, J. L. St. Sauver, W. R. Wilson, and L. M. Baddour Age- and Sex-Associated Trends in Bloodstream Infection: A Population-Based Study in Olmsted County, Minnesota Arch Intern Med, April 23, 2007; 167(8): 834 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Z. Uslan, M. R. Sohail, J. L. St. Sauver, P. A. Friedman, D. L. Hayes, S. M. Stoner, W. R. Wilson, J. M. Steckelberg, and L. M. Baddour Permanent Pacemaker and Implantable Cardioverter Defibrillator Infection: A Population-Based Study Arch Intern Med, April 9, 2007; 167(7): 669 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Wang, E. Athan, P. A. Pappas, V. G. Fowler Jr, L. Olaison, C. Pare, B. Almirante, P. Munoz, M. Rizzi, C. Naber, et al. Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis JAMA, March 28, 2007; 297(12): 1354 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kilic, H. Li, C. W. Stratton, and Y.-W. Tang Antimicrobial Susceptibility Patterns and Staphylococcal Cassette Chromosome mec Types of, as Well as Panton-Valentine Leukocidin Occurrence among, Methicillin-Resistant Staphylococcus aureus Isolates from Children and Adults in Middle Tennessee J. Clin. Microbiol., December 1, 2006; 44(12): 4436 - 4440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Hoen Epidemiology and antibiotic treatment of infective endocarditis: an update. Heart, November 1, 2006; 92(11): 1694 - 1700. [Full Text] [PDF]
|
|
|
|
|
|
S. Hetherington, M. Texter, E. Wenzel, J. M. Patti, L. Reynolds, T. Shamp, and S. Swan Phase I dose escalation study to evaluate the safety and pharmacokinetic profile of tefibazumab in subjects with end-stage renal disease requiring hemodialysis. Antimicrob. Agents Chemother., October 1, 2006; 50(10): 3499 - 3500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Jeffres, W. Isakow, J. A. Doherty, P. S. McKinnon, D. J. Ritchie, S. T. Micek, and M. H. Kollef Predictors of Mortality for Methicillin-Resistant Staphylococcus aureus Health-Care-Associated Pneumonia: Specific Evaluation of Vancomycin Pharmacokinetic Indices. Chest, October 1, 2006; 130(4): 947 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Weems Jr., J. P. Steinberg, S. Filler, J. W. Baddley, G. R. Corey, P. Sampathkumar, L. Winston, J. F. John, C. J. Kubin, R. Talwani, et al. Phase II, Randomized, Double-Blind, Multicenter Study Comparing the Safety and Pharmacokinetics of Tefibazumab to Placebo for Treatment of Staphylococcus aureus Bacteremia. Antimicrob. Agents Chemother., August 1, 2006; 50(8): 2751 - 2755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Kollef Microbiological Diagnosis of Ventilator-associated Pneumonia: Using the Data to Optimize Clinical Outcomes. Am. J. Respir. Crit. Care Med., June 1, 2006; 173(11): 1182 - 1184. [Full Text] [PDF]
|
|
|
|
|
|
M. H. Kollef, A. Shorr, Y. P. Tabak, V. Gupta, L. Z. Liu, and R. S. Johannes Epidemiology and Outcomes of Health-care-Associated Pneumonia: Results From a Large US Database of Culture-Positive Pneumonia Chest, December 1, 2005; 128(6): 3854 - 3862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H Wyllie, T. E A Peto, and D. Crook MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003 BMJ, October 29, 2005; 331(7523): 992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Kollef and K. E. Kollef Antibiotic Utilization and Outcomes for Patients With Clinically Suspected Ventilator-Associated Pneumonia and Negative Quantitative BAL Culture Results Chest, October 1, 2005; 128(4): 2706 - 2713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Hyle, A. D. Lipworth, T. E. Zaoutis, I. Nachamkin, W. B. Bilker, and E. Lautenbach Impact of Inadequate Initial Antimicrobial Therapy on Mortality in Infections Due to Extended-Spectrum {beta}-Lactamase-Producing Enterobacteriaceae: Variability by Site of Infection Arch Intern Med, June 27, 2005; 165(12): 1375 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. G. Fowler Jr, J. M. Miro, B. Hoen, C. H. Cabell, E. Abrutyn, E. Rubinstein, G. R. Corey, D. Spelman, S. F. Bradley, B. Barsic, et al. Staphylococcus aureus Endocarditis: A Consequence of Medical Progress JAMA, June 22, 2005; 293(24): 3012 - 3021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia Am. J. Respir. Crit. Care Med., February 15, 2005; 171(4): 388 - 416. [Full Text] [PDF]
|
|
|
|
|
|
J. R. McDonald, N. D. Friedman, J. E. Stout, D. J. Sexton, and K. S. Kaye Risk Factors for Ineffective Therapy in Patients With Bloodstream Infection Arch Intern Med, February 14, 2005; 165(3): 308 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Micek, S. Ward, V. J. Fraser, and M. H. Kollef A Randomized Controlled Trial of an Antibiotic Discontinuation Policy for Clinically Suspected Ventilator-Associated Pneumonia Chest, May 1, 2004; 125(5): 1791 - 1799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tacconelli, L. Venkataraman, P. C. De Girolami, and E. M. C. D'Agata Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains J. Antimicrob. Chemother., March 1, 2004; 53(3): 474 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Osmon, S. Ward, V. J. Fraser, and M. H. Kollef Hospital Mortality for Patients With Bacteremia Due to Staphylococcus aureus or Pseudomonas aeruginosa Chest, February 1, 2004; 125(2): 607 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Thomsen, H. H. Hundborg, H.-H. Lervang, S. P. Johnsen, H. T. Sorensen, and H. C. Schonheyder Diabetes and Outcome of Community-Acquired Pneumococcal Bacteremia: A 10-year population-based cohort study Diabetes Care, January 1, 2004; 27(1): 70 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Zetola Health Care-Associated Bloodstream Infections Ann Intern Med, August 5, 2003; 139(3): 232 - 232. [Full Text] [PDF]
|
|
|
|
 |
|
 Should All Community-Acquired Infections Be Treated as Such? Journal Watch (General), December 20, 2002; 2002(1220): 2 - 2. [Full Text]
|
|
|
|
|
|
R. Gaynes Health Care-Associated Bloodstream Infections: A Change in Thinking Ann Intern Med, November 19, 2002; 137(10): 850 - 851. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
